<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PRF</journal-id>
<journal-id journal-id-type="hwp">spprf</journal-id>
<journal-id journal-id-type="nlm-ta">Perfusion</journal-id>
<journal-title>Perfusion</journal-title>
<issn pub-type="ppub">0267-6591</issn>
<issn pub-type="epub">1477-111X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0267659112458136</article-id>
<article-id pub-id-type="publisher-id">10.1177_0267659112458136</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Evaluation of the new generation dual-lumen catheter for neonatal ECMO</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Said</surname><given-names>MM</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112458136">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rivera</surname><given-names>O</given-names></name>
<xref ref-type="aff" rid="aff2-0267659112458136">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mikesell</surname><given-names>GT</given-names></name>
<xref ref-type="aff" rid="aff3-0267659112458136">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rais-Bahrami</surname><given-names>K</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112458136">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0267659112458136"><label>1</label>Department of Neonatology, Children’s National Medical Center and The George Washington University School of Medicine, Washington, DC, USA</aff>
<aff id="aff2-0267659112458136"><label>2</label>Department of Biomedical Engineering, Children’s National Medical Center and The George Washington University School of Medicine, Washington, DC, USA</aff>
<aff id="aff3-0267659112458136"><label>3</label>Department of Cardiovascular Surgery, Children’s National Medical Center and The George Washington University School of Medicine, Washington, DC, USA</aff>
<author-notes>
<corresp id="corresp1-0267659112458136">Mariam M Said Department of Neonatology Children’s National Medical Center 111 Michigan Avenue, NW Washington, DC, USA 20010 Email: <email>msaid@childrensnational.org</email></corresp>
<fn fn-type="other">
<p>Presented at the Eastern Society of Pediatric Research April 2012 and the American Pediatric Society, May 2012.</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>1</issue>
<fpage>26</fpage>
<lpage>30</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0267659112458136">
<title>Objectives:</title>
<p>The purpose of this study was to compare the newly designed dual-lumen venovenous catheter (VR13, OriGen Biomedical, Austin, TX) with the current dual-lumen catheter (VV12, OriGen Biomedical).</p>
</sec>
<sec id="section2-0267659112458136">
<title>Methods:</title>
<p>Five newborn lambs, 1 to 5 days old and weighing 4.2 ± 0.5 kg, were cannulated with the VV13 OriGen catheter and placed on extracorporeal membrane oxygenation (ECMO). ECMO flows were increased from 200 to 600 ml/min, with measurements taken after the changes. The experiment was then repeated using the VV12 catheter.</p>
</sec>
<sec id="section3-0267659112458136">
<title>Results:</title>
<p>Recirculation values were equal for both catheters. The pressure drop at the reinfusion port was equal for both catheters at 200 ml/min, increasing to 275 mmHg at 500 ml/min for the VR13 vs. 240 mmHg for the VV12 catheter.</p>
</sec>
<sec id="section4-0267659112458136">
<title>Conclusion:</title>
<p>These findings indicate that the VR13 catheter resulted in levels of recirculation equal to the VV12. Based on resistance measurements, we do not recommend the use of this new catheter beyond 400 ml/min until minor design changes are made.</p>
</sec>
</abstract>
<kwd-group>
<kwd>catheter</kwd>
<kwd>ECMO</kwd>
<kwd>lamb</kwd>
<kwd>oxygenation</kwd>
<kwd>venovenous</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section5-0267659112458136" sec-type="intro">
<title>Introduction</title>
<p>The <italic>gold standard</italic> for ECMO therapy has been venoarterial ECMO. In the last decade, an alternative approach using a single, dual-lumen catheter for venovenous ECMO has been used with increasing frequency for neonates with severe respiratory failure.<sup><xref ref-type="bibr" rid="bibr1-0267659112458136">1</xref>,<xref ref-type="bibr" rid="bibr2-0267659112458136">2</xref></sup> The catheter is designed to be inserted into the right atrium with return of arterial (oxygenated) blood directed toward the tricuspid valve. The venous drainage to the ECMO circuit is through holes offset from the arterial outlet. The most attractive feature of the dual-lumen catheter is the single-site cannulation of the internal jugular vein, thereby, sparing the carotid artery.<sup><xref ref-type="bibr" rid="bibr1-0267659112458136">1</xref><xref ref-type="bibr" rid="bibr2-0267659112458136"/><xref ref-type="bibr" rid="bibr3-0267659112458136"/>–<xref ref-type="bibr" rid="bibr4-0267659112458136">4</xref></sup> The limitations for venovenous ECMO are the size of the internal jugular vein, severe cardiac dysfunction, hypotension and profound metabolic acidosis on maximal inotropic support.<sup><xref ref-type="bibr" rid="bibr2-0267659112458136">2</xref><xref ref-type="bibr" rid="bibr3-0267659112458136"/>–<xref ref-type="bibr" rid="bibr4-0267659112458136">4</xref></sup> In some patients, optimal arterial oxygenation cannot be achieved despite high extracorporeal blood flow rates. This is due to recirculation of the oxygenated blood caused by the dual-lumen catheter design, limiting the efficiency of the bypass.<sup><xref ref-type="bibr" rid="bibr5-0267659112458136">5</xref></sup> As blood flow rates are increased, turbulence in the right atrium is increased, thereby, increasing recirculation.</p>
<p>The original design of the OriGen dual-lumen catheter for use in neonatal venovenous ECMO was developed at Children’s National Medical Center (CNMC) and has been widely used clinically (OriGen Biomedical, Austin TX). The OriGen catheter is made with external diameters of 12, 15 and 18 French to accommodate extracorporeal life support for neonates to young infants.<sup><xref ref-type="bibr" rid="bibr6-0267659112458136">6</xref></sup> Recently, OriGen has made changes to the catheter to improve its mechanical characteristics, particularly in the area of kink resistance and preventing collapse by wire re-enforcing the catheter. This has resulted in elimination of some of the reinfusion side holes (<xref ref-type="fig" rid="fig1-0267659112458136">Figure 1</xref>).The original dual-lumen catheter has multiple small side-holes for blood return from the ECMO circuit to the patient. The new design has incorporated one elliptically shaped reinfusion port (<xref ref-type="fig" rid="fig2-0267659112458136">Figure 2</xref>).</p>
<fig id="fig1-0267659112458136" position="float">
<label>Figure 1.</label>
<caption>
<p>Schematic of the new 13 Fr. OriGen catheter, with a close-up view of the catheter tip.</p>
</caption>
<graphic xlink:href="10.1177_0267659112458136-fig1.tif"/>
</fig>
<fig id="fig2-0267659112458136" position="float">
<label>Figure 2.</label>
<caption>
<p>Schematic of the new 13 Fr. OriGen catheter tip (top) compared to the existing 12 Fr. OriGen catheter tip (bottom).</p>
</caption>
<graphic xlink:href="10.1177_0267659112458136-fig2.tif"/>
</fig>
<p>The purpose of this study was to compare the newly designed dual-lumen catheter by OriGen with the existing dual-lumen catheter to ensure its safety and efficacy prior to use in human neonates.</p>
</sec>
<sec id="section6-0267659112458136" sec-type="methods">
<title>Methods</title>
<p>This study was approved by the Institutional Animal Use and Care Committee (IACUC) at Children’s National Medical Center. The care and handling of the animals was in accordance with the National Institute of Health guidelines.</p>
<sec id="section7-0267659112458136">
<title>Subjects</title>
<p>Five newborn lambs, 1 to 5 days old with a mean weight of 4.2 ± 0.5 Kg, were used for this study.</p>
</sec>
<sec id="section8-0267659112458136">
<title>Surgical Preparation</title>
<p>Anesthesia was induced with 40 mg/kg of ketamine hydrochloride (Ketalar<sup>®</sup>, Parke-Davis, Morris Plains, NJ) and 5 mg/kg bodyweight of xylazine (Rompun<sup>®</sup>, Miles, Agriculture Division, Animal Health Products, Shawnee Mission, KS) intramuscularly. A pentobarbital infusion was then administered at 3-5 mg/kg/hr intravenously via a percutaneously inserted central venous catheter (PICC) to maintain continuous anesthesia. The animals were intubated and ventilated to maintain normal blood gas values. Femoral arterial and venous lines were placed via a right femoral cut-down. After one hour of post-operative stabilization, the animals were systemically heparinized with 200 units/kg of heparin. The right internal jugular vein was isolated and cannulated with the 13 Fr. OriGen catheter (Code: VR 13) for venovenous ECMO support. A cephalic jugular venous line was inserted into the contralateral proximal internal jugular vein and positioned at the base of the skull (jugular bulb) to obtain samples for cerebral venous saturation measurements.</p>
</sec>
<sec id="section9-0267659112458136">
<title>Study Design</title>
<p>The animals were stabilized on venovenous ECMO, using our standard neonatal ECMO circuit. The ventilator settings were maintained at a peak inspiratory pressure/positive end expiratory pressure (PIP/PEEP) of 15/5 cmH<sub>2</sub>O, intermittent mandatory ventilation rate (IMV) of 15-25 breaths/min and fraction of inspired oxygen (FiO<sub>2</sub>) of 0.30. The ventilator settings and FiO<sub>2</sub> were kept constant during each study. ECMO flows were increased in 100-ml increments from 200 to 600 ml/min, with measurements taken 15-20 minutes after each change. The reinforced 13Fr. OriGen catheter was then replaced by the standard 12 Fr. OriGen catheter (Code: VV 12) and the studies were repeated. Each study began with the 13 Fr. OriGen catheter followed by the 12 Fr. OriGen catheter. Due to vascular constriction over time, the slightly larger cannula acted as a vascular dilator, allowing re-cannulation without compromising the vessel. It would have been technically difficult to replace the first catheter with a larger size without risking venous ruptures and potential loss of the animals. The animals remained stable during the study and tolerated the re-cannulation well.</p>
<p>Studies included: measurements of heart rate, mean arterial pressure, partial pressure of arterial oxygen levels (PaO<sub>2</sub>), saturation values from the jugular bulb catheter approximating cerebral saturations, and femoral arterial, venous and pump venous oxygen saturations. Pre- and post-membrane circuit pressures were also measured at flows of 200 to 600 ml/min.</p>
<p>Post-mortem necropsy was performed on each animal to verify catheter positioning. Additionally, tissues were evaluated for any endothelial erosion, given a new design change incorporating a single reinfusion port.</p>
<sec id="section10-0267659112458136">
<title>Data Analysis</title>
<p>A standard recirculation measurements formula, using pre-oxygenator saturation, post-oxygenator saturation and circuit mixed venous saturations, was used to calculate recirculation for each catheter tested at different bypass flow rates, deriving from the following equation:</p>
<p><disp-formula id="disp-formula1-0267659112458136">
<mml:math display="block" id="math1-0267659112458136">
<mml:mrow>
<mml:mtext>R</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mtext>SPreox</mml:mtext>
<mml:mo>−</mml:mo>
<mml:mtext>SV</mml:mtext>
<mml:msub>
<mml:mtext>O</mml:mtext>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>/</mml:mo>
<mml:mtext>SPostox</mml:mtext>
<mml:mo>−</mml:mo>
<mml:mtext>SV</mml:mtext>
<mml:msub>
<mml:mtext>O</mml:mtext>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula1-0267659112458136" xlink:href="10.1177_0267659112458136-eq1.tif"/>
</disp-formula></p>
</sec>
</sec>
</sec>
<sec id="section11-0267659112458136" sec-type="results">
<title>Results</title>
<p>Recirculation values were equal for both catheters, ranging from 5% at 200 ml/min to a maximum of 35% at 500 ml/min (<xref ref-type="fig" rid="fig3-0267659112458136">Figure 3</xref>). The pressure drop at the reinfusion port was 75 mmHg for both catheters at 200 ml/min and exponentially increased to 275 mmHg at 500 ml/min for the new Origen 13 Fr. catheter vs. 240 mmHg for the existing 12 Fr. catheter (<xref ref-type="fig" rid="fig4-0267659112458136">Figure 4</xref>).</p>
<fig id="fig3-0267659112458136" position="float">
<label>Figure 3.</label>
<caption>
<p>Percent recirculation measurements for ECMO flows of 200-500 ml/min. Current OriGen catheter <italic>(Red)</italic> and new OriGen catheter <italic>(Blue)</italic>.</p>
</caption>
<graphic xlink:href="10.1177_0267659112458136-fig3.tif"/></fig>
<fig id="fig4-0267659112458136" position="float">
<label>Figure 4.</label>
<caption>
<p>Pressure drop measurements at reinfusion port for ECMO flows of 200-500 ml/min. Current OriGen catheter <italic>(Red)</italic> and new OriGen catheter <italic>(Blue)</italic>.</p>
</caption>
<graphic xlink:href="10.1177_0267659112458136-fig4.tif"/></fig>
<p>Post-mortem necropsy did not show any evidence of endothelial erosion after several hours of veno-venous ECMO, using the new reinforced catheter with a single reinfusion port.</p>
</sec>
<sec id="section12-0267659112458136" sec-type="discussion">
<title>Discussion</title>
<p>Although venoarterial ECMO remains the gold standard for neonates who fail to respond to maximal mechanical ventilatory and pharmacologic support,<sup><xref ref-type="bibr" rid="bibr1-0267659112458136">1</xref>,<xref ref-type="bibr" rid="bibr2-0267659112458136">2</xref></sup> increasing numbers of neonates are being treated with venovenous ECMO using the dual-lumen venovenous catheters.<sup><xref ref-type="bibr" rid="bibr1-0267659112458136">1</xref>,<xref ref-type="bibr" rid="bibr4-0267659112458136">4</xref></sup> This allows for a single cannulation site, sparing carotid artery ligation.<sup><xref ref-type="bibr" rid="bibr1-0267659112458136">1</xref><xref ref-type="bibr" rid="bibr2-0267659112458136"/><xref ref-type="bibr" rid="bibr3-0267659112458136"/><xref ref-type="bibr" rid="bibr4-0267659112458136"/><xref ref-type="bibr" rid="bibr5-0267659112458136"/>–<xref ref-type="bibr" rid="bibr6-0267659112458136">6</xref></sup> The dual-lumen venovenous cannula can also eliminate other concerns of venoarterial ECMO, such as increased pulmonary vascular resistance,<sup><xref ref-type="bibr" rid="bibr7-0267659112458136">7</xref></sup> compromised regional blood flow to vital organs,<sup><xref ref-type="bibr" rid="bibr8-0267659112458136">8</xref></sup> decreased coronary artery oxygen transport,<sup><xref ref-type="bibr" rid="bibr4-0267659112458136">4</xref>,<xref ref-type="bibr" rid="bibr9-0267659112458136">9</xref></sup> impaired cardiac performance<sup><xref ref-type="bibr" rid="bibr10-0267659112458136">10</xref>,<xref ref-type="bibr" rid="bibr11-0267659112458136">11</xref></sup> and altered cerebral perfusion and autoregulation.<sup><xref ref-type="bibr" rid="bibr12-0267659112458136">12</xref>,<xref ref-type="bibr" rid="bibr13-0267659112458136">13</xref></sup></p>
<p>Because of its design, the reinforced OriGen catheter has advantages of improving the mechanical characteristics, particularly in the areas of kink resistance and preventing collapse by wire reinforcing the catheter. The disadvantage of the new catheter is the reconfiguration of the reinfusion side-holes. The original dual-lumen catheter has multiple small side-holes for blood return from the ECMO circuit to the patient. The new design has incorporated one elliptically shaped reinfusion port which changed flow dynamics of the reinfused bloodstream and made it very difficult to direct the blood return toward the tricuspid valve without meticulous positioning during the catheter placement.</p>
<p>Although this study was limited to a small number of animals, each study subject was used as its own control. Therefore, recirculation measurements for both catheters indicate that the recirculation remains minimized with this newly designed catheter, making the OriGen dual-lumen catheter efficient in venovenous ECMO support. The design of the OriGen catheter makes the oxygenation capability of venovenous ECMO almost equivalent to venoarterial ECMO, provided its optimum positioning within the right atrium with arterial side-hole(s) is directed towards the tricuspid valve. The currently available OriGen catheters, made in three different sizes, allow for its use in neonates as well as in older pediatric patients.</p>
<p>Once appropriately positioned, our study demonstrated that the reinforced OriGen catheter resulted in equal levels of recirculation when compared to the currently available catheter. Pressure drop was slightly higher for the reinforced catheter, contributing to potentially more circuit complications as well as an increased risk of hemolysis.</p>
</sec>
<sec id="section13-0267659112458136" sec-type="conclusions">
<title>Conclusion</title>
<p>The reinforced OriGen 13 Fr. catheter resulted in equal levels of recirculation when compared with the currently available catheter. However, in order to achieve these levels of recirculation, it required meticulous positioning when compared to the current catheter. Pressure drop was slightly higher for the newly designed catheter. Based on resistance measurements, we do not recommend the use of this new catheter beyond 400 ml/min. We recommend that the new catheter design incorporates the four return side-holes as in its original design, with the added benefit of wire reinforcement of the proximal part of the catheter.</p>
<p>The manufacturer is currently studying design alterations of the reinfusion side-holes of the catheter to incorporate it with the kink-resistant design.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of Interest Statement</label>
<p>The authors have no conflicts of interest to declare.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0267659112458136">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cornish</surname><given-names>JD</given-names></name>
<name><surname>Heiss</surname><given-names>KF</given-names></name>
<name><surname>Clark</surname><given-names>RH</given-names></name>
<name><surname>Strieper</surname><given-names>MJ</given-names></name>
<name><surname>Boecler</surname><given-names>B</given-names></name>
<name><surname>Kesser</surname><given-names>K</given-names></name>
</person-group>. <article-title>Efficacy of venovenous extracorporeal membrane oxygenation for neonates with respiratory and circulatory compromise</article-title>. <source>J Pediatrics</source> <year>1993</year>; <volume>122</volume>: <fpage>105</fpage>–<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr2-0267659112458136">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Delius</surname><given-names>R</given-names></name>
<name><surname>Anderson</surname><given-names>HL</given-names></name>
<name><surname>Schumacher</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Venovenous compares favorably with venoarterial access for extracorporeal membrane oxygenation in neonatal respiratory failure</article-title>. <source>J Thoracic and Cardiovasc Surg</source> <year>1993</year>; <volume>106</volume>: <fpage>329</fpage>–<lpage>338</lpage>.</citation>
</ref>
<ref id="bibr3-0267659112458136">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knight</surname><given-names>GR</given-names></name>
<name><surname>Dudell</surname><given-names>GG</given-names></name>
<name><surname>Evans</surname><given-names>ML</given-names></name>
<name><surname>Grimm</surname><given-names>PS</given-names></name>
</person-group>. <article-title>A comparison of venovenous and venoarterial extracorporeal membrane oxygenation in the treatment of neonatal respiratory failure</article-title>. <source>Crit Care Med</source> <year>1996</year>; <volume>24</volume>: <fpage>1678</fpage>–<lpage>1683</lpage>.</citation>
</ref>
<ref id="bibr4-0267659112458136">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>HL</given-names></name>
<name><surname>Snedecor</surname><given-names>SM</given-names></name>
<name><surname>Otsu</surname><given-names>T</given-names></name>
<name><surname>Bartlett</surname><given-names>RH</given-names></name>
</person-group>. <article-title>Multicenter comparison of conventional venovenous access versus venovenous double-lumen catheter access in newborn infants undergoing extracorporeal membrane oxygenation</article-title>. <source>J Pediatr Surg</source> <year>1993</year>; <volume>28</volume>: <fpage>530</fpage>–<lpage>535</lpage>.</citation>
</ref>
<ref id="bibr5-0267659112458136">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rais-Bahrami</surname><given-names>K</given-names></name>
<name><surname>Rivera</surname><given-names>O</given-names></name>
<name><surname>Mikesell</surname><given-names>GT</given-names></name>
<etal/>
</person-group>. <article-title>Improved oxygenation with reduced recirculation during venovenous extracorporeal membrane oxygenation. Evaluation of a test catheter</article-title>. <source>Crit Care Med</source> <year>1995</year>; <volume>23</volume>: <fpage>1722</fpage>–<lpage>1725</lpage>.</citation>
</ref>
<ref id="bibr6-0267659112458136">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rais-Bahrami</surname><given-names>K</given-names></name>
<name><surname>Walton</surname><given-names>DM</given-names></name>
<name><surname>Sell</surname><given-names>JE</given-names></name>
<name><surname>Rivera</surname><given-names>O</given-names></name>
<name><surname>Mikesell</surname><given-names>GT</given-names></name>
<name><surname>Short</surname><given-names>BL</given-names></name>
</person-group>. <article-title>Improved oxygenation with reduced recirculation during venovenous ECMO. Comparison of two catheters</article-title>. <source>Perfusion</source> <year>2002</year>; <volume>17</volume>: <fpage>415</fpage>–<lpage>419</lpage>.</citation>
</ref>
<ref id="bibr7-0267659112458136">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stolar</surname><given-names>CJ</given-names></name>
<name><surname>Dillon</surname><given-names>PW</given-names></name>
</person-group>. <article-title>Modification of cardiopulmonary hemodynamics and vasoactive mediators by extracorporeal membrane oxygenation in newborn lambs</article-title>. <source>J Pediatr Surg</source> <year>1990</year>; <volume>25</volume>: <fpage>33</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr8-0267659112458136">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Newlen</surname><given-names>TT</given-names></name>
<name><surname>Salley</surname><given-names>SO</given-names></name>
<name><surname>Whittlesey</surname><given-names>GC</given-names></name>
<etal/>
</person-group>. <article-title>Regional blood flow distribution during extracorporeal membrane oxygenation in rabbits</article-title>. <source>J Thoracic Cardiovasc Surg</source> <year>1989</year> <volume>98</volume>: <fpage>1138</fpage>–<lpage>1143</lpage>.</citation>
</ref>
<ref id="bibr9-0267659112458136">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kinsella</surname><given-names>JP</given-names></name>
<name><surname>Gerstmann</surname><given-names>DR</given-names></name>
<name><surname>Rosenberg</surname><given-names>AA</given-names></name>
</person-group>. <article-title>The effect of extracorporeal membrane oxygenation on coronary perfusion and regional blood flow distribution</article-title>. <source>Pediatr Res</source> <year>1992</year>; <volume>31</volume>: <fpage>80</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr10-0267659112458136">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hirschl</surname><given-names>RB</given-names></name>
<name><surname>Heiss</surname><given-names>KF</given-names></name>
<name><surname>Bartlett</surname><given-names>RH</given-names></name>
</person-group>. <article-title>Severe myocardial dysfunction during extracorporeal membrane oxygenation</article-title>. <source>J Pediatr Surg</source> <year>1992</year>; <volume>27</volume>: <fpage>48</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr11-0267659112458136">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kimball</surname><given-names>TR</given-names></name>
<name><surname>Daniels</surname><given-names>SR</given-names></name>
<name><surname>Weiss</surname><given-names>RG</given-names></name>
<etal/>
</person-group>. <article-title>Changes in cardiac function during extracorporeal membrane oxygenation for persistent pulmonary hypertension in newborn infants</article-title>. <source>J Pediatr</source> <year>1991</year>; <volume>118</volume>: <fpage>431</fpage>–<lpage>436</lpage>.</citation>
</ref>
<ref id="bibr12-0267659112458136">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Short</surname><given-names>BL</given-names></name>
<name><surname>Walker</surname><given-names>LK</given-names></name>
<name><surname>Bender</surname><given-names>KS</given-names></name>
<name><surname>Traystman</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>Impairment of cerebral autoregulation during extracorporeal membrane oxygenation in newborn lambs</article-title>. <source>Pediatr Res</source> <year>1993</year>; <volume>33</volume>: <fpage>289</fpage>–<lpage>294</lpage>.</citation>
</ref>
<ref id="bibr13-0267659112458136">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fukuda</surname><given-names>S</given-names></name>
<name><surname>Aoyama</surname><given-names>M</given-names></name>
<name><surname>Yamada</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Comparison of venoarterial versus venovenous access in the cerebral circulation of newborns undergoing extracorporeal membrane oxygenation</article-title>. <source>Pediatr Surg Int</source> <year>1999</year>; <volume>15</volume>: <fpage>78</fpage>–<lpage>84</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>